Keller J, Gerber R, Del Tito B J, Vannicolo D, Arcuri E J
Department of Biological Process Sciences, Smith Kline Beecham Pharmaceuticals, King of Prussia, PA 19406.
J Ind Microbiol. 1990 Nov;6(3):199-206. doi: 10.1007/BF01577696.
The major leftward early promoter of phage lambda pL, has frequently been used to drive expression of heterologous genes in Escherichia coli. pL is typically maintained fully repressed by the lambda cl protein. When induction of heterologous protein synthesis is desired, one of several potential mechanisms of destroying cl function is employed and the expression of the foreign gene commences. One method of derepressing pL involves exposing cells to nalidixic acid, which results in the "activation" of RecA protein and the subsequent RecA-mediated proteolytic cleavage of cl. Activated RecA also mediates the cleavage of the E. coli LexA protein, resulting in induction of the SOS regulon (at least 15 E. coli genes, including recA). We have examined the effect of two chromosomal mutations on the productivity of nalidixic acid inductions. One of the tested mutations (recA o) increased the intracellular concentration of RecA prior to induction; the other (lexAind-) resulted in a mutated lexA protein insensitive to RecA-mediated cleavage. These mutations were introduced into a strain carrying a cl+ defective lysogen. Synthesis of two heterologous proteins, human alpha 1-antitrypsin and a fusion protein partially derived from the Plasmodium falciparum circumsporozoite surface antigen, was examined in the wild-type and mutant strains. The maximum alpha-1 antitrypsin concentration achieved was improved by 50% when the recA o strain was used rather than the wild-type; however, only smaller changes (20% or less) in the maximum concentration of the malaria fusion protein were observed. Use of the lexAind- strain resulted in a decrease in the maximum concentration attained for both heterologous products.
噬菌体λ的主要向左早期启动子pL,经常被用于驱动大肠杆菌中异源基因的表达。pL通常被λcl蛋白完全抑制。当需要诱导异源蛋白合成时,会采用几种破坏cl功能的潜在机制之一,然后外源基因开始表达。去抑制pL的一种方法是将细胞暴露于萘啶酸,这会导致RecA蛋白“激活”,随后RecA介导cl的蛋白水解切割。活化的RecA还介导大肠杆菌LexA蛋白的切割,导致SOS调节子(至少15个大肠杆菌基因,包括recA)的诱导。我们研究了两个染色体突变对萘啶酸诱导效率的影响。其中一个测试突变(recA o)在诱导前增加了RecA的细胞内浓度;另一个(lexAind-)导致产生对RecA介导的切割不敏感的突变lexA蛋白。这些突变被引入携带cl+缺陷溶原菌的菌株中。在野生型和突变型菌株中检测了两种异源蛋白的合成,即人α1-抗胰蛋白酶和部分源自恶性疟原虫环子孢子表面抗原的融合蛋白。使用recA o菌株时,达到的最大α1-抗胰蛋白酶浓度比野生型提高了50%;然而,疟原虫融合蛋白的最大浓度仅观察到较小的变化(20%或更小)。使用lexAind-菌株导致两种异源产物达到的最大浓度均降低。